VitalFlow Healthy Volunteer Study
Determination of Threshold of Stimulation, Tolerability and Safety of Magnetic Nerve Stimulation In Healthy Subjects: an Exploratory Study
1 other identifier
interventional
37
1 country
1
Brief Summary
Find the stimulation threshold of the facial nerve (ganglion Geniculate) associated with tolerability and safety in subjects Healthy humans.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2015
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 19, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
January 8, 2016
CompletedFirst Submitted
Initial submission to the registry
June 17, 2017
CompletedFirst Posted
Study publicly available on registry
April 4, 2018
CompletedApril 4, 2018
March 1, 2018
2 months
June 17, 2017
March 27, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in perfusion index of cerebral blood flow
An algorithm to calculate the perfusion index using magnetic resonance images across the entire brain
10 minutes post-stimulation
Study Arms (1)
Vitalflow treatment
EXPERIMENTALThe subject's exposure will be through a ramp model of increments in magnetic stimulation power delivered to the facial nerves bilaterally. Increases in magnetic stimulation will be 10% for 10 seconds from 10% to 60%. Subsequent to this will be evaluated for 5 minutes in the power of tolerability of the subject (60% 70%, 80% or 90%).
Interventions
Eligibility Criteria
You may qualify if:
- Healthy subjects
You may not qualify if:
- Subjects with a diagnosis of epilepsy, seizures, facial nerve palsy, migraine or recurrent headaches, glaucoma or neuropathies.
- Subjects in breastfeeding or in pregnancy. (To be confirmed with test strip).
- Subjects with acute or acute chronic medical conditions.
- Age less than 20 years or greater than 40 years.
- Carotid surgery.
- Episodes of syncope.
- Known arteriosclerosis anywhere on the body
- Metal implants (cochlear implants, pacemakers, metal prostheses).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centro Nacional de Investigación en Imagenología e Instrumentación Medica
Mexico City, Mexico City, 09340, Mexico
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 17, 2017
First Posted
April 4, 2018
Study Start
October 19, 2015
Primary Completion
December 15, 2015
Study Completion
January 8, 2016
Last Updated
April 4, 2018
Record last verified: 2018-03
Data Sharing
- IPD Sharing
- Will share
available from investigators authors upon reasonable request